Post

New research · Ophthalmology
Cancers · 1d
Cohort studyCancers · 2026

Comparison of MOLES and Mel AI noma for Differentiating Small Choroidal Melanomas from Nevi.

Katerina Stripling, Hannah Coudé Adam, Mats Holmström, Gustav Stålhammar
Read paper
OphthalmologyCohort study

AI algorithm Mel AI noma more strongly linked to melanoma diagnosis than MOLES score

Comparison of MOLES and Mel AI noma for Differentiating Small Choroidal Melanomas from Nevi.

Katerina Stripling … Gustav Stålhammar
Cancers · 2026
Background

Early identification of small choroidal melanomas is important, as metastatic risk increases with tumor size.

Purpose

This study aims to compare the association between MOLES and Mel AI noma scores and to assess their relative association with expert melanoma versus nevus diagnosis.

Methods

In this retrospective cohort study, 86 patients with small pigmented choroidal lesions (29 melanomas and 57 nevi) diagnosed at a national ocular oncology referral center were included.

n = 86 patients
Results

Mel AI noma's score predicts a melanoma diagnosis better than MOLES score does

0.38R²
Mel AI noma
0.27R²
MOLES
More results

Mel AI noma scores increased monotonically with higher MOLES categories ( p = 0.0001).

In univariable logistic regression, both MOLES and Mel AI noma scores were associated with increased odds of melanoma diagnosis.

In multivariable analysis including both scores, each remained independently associated with melanoma diagnosis.

“
Conclusion · 1 of 2

Both MOLES and Mel AI noma are effective for differentiating small choroidal melanomas from nevi. Although the scores are statistically associated, they capture partly distinct information.

Conclusion · 2 of 2

Mel AI noma demonstrates slightly stronger association with melanoma diagnosis and provides fully reproducible output, supporting its role as a complementary aid in lesion triage.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving